Vivian Y. Shin - Publications

Rapid Breakpoint Mapping of a Novel Germline PALB2 Duplication by PCR-Free Long-Read Sequencing for Interpretation of Its Pathogenicity.

Journal: JCO precision oncology

Published: January 07, 2022

Molecular characteristics of Asian male BRCA-related cancers.

Journal: Breast cancer research and treatment

Published: December 01, 2021

Germline mutations in Chinese ovarian cancer with or without breast cancer.

Journal: Molecular genetics & genomic medicine

Published: September 28, 2021

Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 16, 2021

Inhibition of EP2 receptor suppresses tumor growth and chemoresistance of gastric cancer.

Journal: American journal of cancer research

Published: August 05, 2021

MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1.

Journal: American journal of translational research

Published: July 20, 2021

Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients.

Journal: Cancers

Published: July 16, 2021

How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Journal: BMC medical genomics

Published: June 24, 2021

A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient.

Journal: International journal of molecular sciences

Published: December 07, 2020

Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing.

Journal: American journal of cancer research

Published: July 02, 2020

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.

Journal: BMC cancer

Published: May 27, 2020

Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment.

Journal: Pediatric research

Published: February 06, 2020